Unusual clonal chromosomal evolution in a breast carcinoma and its lymph node metastasis in a patient with down syndrome
✍ Scribed by Jacqueline Bernardino; Michèle Gerbault-Seureau; Xavier Sastre; Bernard Dutrillaux
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 127 KB
- Volume
- 19
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: The ability of a solid tumor to grow and metastasize has a significant dependence on protease systems, such as the plasminogen activation system. the plasminogen activation system includes the urokinase-type plasminogen activator (upa) and plasminogen activator inhibitor type 1 (pai-
## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly